---All---
  • ---All---
  • Accession
  • Catalog #

Phospho-LC3C-S137/138 AntibodyPeptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP3531a 0.1 mg 400 ul In Stock $ 120.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Phospho-LC3C-S137/138 Antibody - Product info

ApplicationDB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ9BXW4
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW16852 Da

Phospho-LC3C-S137/138 Antibody - Additional info

Gene ID 440738
Other Names
MAP1LC3C; Microtubule-associated proteins 1A/1B light chain 3C; Autophagy-related protein LC3 C; Autophagy-related ubiquitin-like modifier LC3 C; MAP1 light chain 3-like protein 3; MAP1A/MAP1B light chain 3 C; Microtubule-associated protein 1 light chain 3 gamma
Target/Specificity
This Phospho-LC3C-S137/138 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide between 118~147 amino acids surrounding S137/138 of human LC3 (APG8c). Patent pending.
Dilution
DB~~1:500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
Phospho-LC3C-S137/138 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

Phospho-LC3C-S137/138 Antibody - Protein Information

Name MAP1LC3C
Function
Probably involved in formation of autophagosomal vacuoles (autophagosomes) (By similarity)
Cellular Location
Cytoplasm, cytoskeleton. Endomembrane system; Lipid-anchor. Cytoplasmic vesicle, autophagosome membrane; Lipid-anchor. Note=LC3-II binds to the autophagic membranes
Tissue Location
Most abundant in placenta, lung and ovary.

Phospho-LC3C-S137/138 Antibody - Related products

AP1804a: LC3 Antibody (APG8C) (N-term)

AP1804e: LC3 Antibody (APG8C) (T48)

AP1804f: LC3 Antibody (APG8C) (Y105)

AP3457a: Phospho-LC3C-S9 Antibody

AP3531a: Phospho-LC3C-S137/138 Antibody

AP3646a: Phospho-LC3C-T48 Antibody

AP3691a: Phospho-APG8c (MAP1LC3C)-Y105 Antibody

RI13152: MAP1LC3C predesign siRNA

BP1804a: LC3 Antibody (APG8c) (N-term) Blocking Peptide

BP1804e: APG8c (MAP1LC3C) Antibody (T48) Blocking Peptide

BP1804f: APG8c (MAP1LC3C) Antibody (Y105) Blocking Peptide

BP3457a: Phospho-LC3 (APG8c) - S9 Antibody Blocking Peptide

BP3531a: Phospho-LC3 (APG8c) - S137/138 Antibody Blocking Peptide

BP3646a: Phospho-APG8c (MAP1LC3C)-T48 Antibody Blocking Peptide

BP3647a: Phospho-APG8c (MAP1LC3C)-Y105 Antibody Blocking Peptide

BP3691a: Phospho-APG8c (MAP1LC3C)-Y105 Antibody Blocking Peptide

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. These proteins are involved in formation of autophagosomal vacuoles (autophagosomes). MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. MAP1LC3c is one of the light chain subunits and can associate with either MAP1A or MAP1B. The precursor molecule is cleaved by APG4B/ATG4B to form the cytosolic form, LC3-I. This is activated by APG7L/ATG7, transferred to ATG3 and conjugated to phospholipid to form the membrane-bound form, LC3-II.

REFERENCES

Baehrecke EH. Nat Rev Mol Cell Biol. 6(6):505-10. (2005) Lum JJ, et al. Nat Rev Mol Cell Biol. 6(6):439-48. (2005) Greenberg JT. Dev Cell. 8(6):799-801. (2005) Levine B. Cell. 120(2):159-62. (2005) Shintani T and Klionsky DJ. Science. 306(5698):990-5. (2004) Tanida I., et al. Int. J. Biochem. Cell Biol. 36:2503-2518(2004) He H., et al. J. Biol. Chem. 278:29278-29287(2003) Tanida I., et al. J. Biol. Chem. 279:36268-36276(2004)